Saúde
ESPA3 — MPM CORPÓREOS S.A.
CNPJ 26.659.061/0001-59 · listed classes: ESPA3 · CVM code 25445
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE ⟶ | 25.6%! | 23.3% | 34.4% | -6.3% | -2.7% | 0.3% | 1.8% |
| ROIC ⟶ | 19.0%! | 6.3%! | 20.5% | 4.5%! | 4.5%! | 5.4%! | 6.4%! |
| ROA ⟶ | 5.8%! | 4.6% | 9.7% | -2.3% | -1.1% | 0.1% | 0.6% |
| Gross margin ⟶ | 55.9% | 45.7% | 40.7% | 36.4% | 37.0% | 33.5% | 34.1% |
| EBIT margin ⟶ | 24.5% | 13.2% | 32.0% | 11.5% | 12.7% | 14.6% | 15.7% |
| Net margin ⟶ | 10.1% | 11.3% | 25.1% | -5.7% | -2.5% | 0.2% | 1.2% |
| Revenue growth (1y) ⟶ | — | -19.4% | 36.9% | 26.9% | 11.0% | 2.3% | 6.1% |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 9.7% | 15.9% |
| Net debt/EBITDA ⟶ | 1.21x | 2.83x | 2.55x | 3.54x | 3.21x | 2.58x | 2.30x |
| Current ratio ⟶ | 1.07x | 1.30x | 1.12x | 1.74x | 1.00x | 1.49x | 1.69x |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1! | 273.6 | 5.6 | 2.0% | -15.2 | 0.42 | 2024-05-09 |
| 2024T2! | 248.9 | 1.3 | 0.5% | -30.6 | 0.44 | 2024-08-08 |
| 2024T3! | 237.5 | -10.0 | -4.2% | -17.9 | 0.44 | 2024-11-07 |
| 2025T1 | 279.4 | 12.1 | 4.3% | 33.6 | 0.34 | 2025-05-07 |
| 2025T2 | 259.2 | 2.1 | 0.8% | 42.5 | 0.47 | 2025-08-06 |
| 2025T3 | 266.0 | -9.1 | -3.4% | 37.4 | 0.49 | 2025-11-06 |
| 2026T1 | 288.1 | 11.9 | 4.1% | 22.9 | 0.42 | 2026-05-06 |
| 2026T2 | 257.5 | -5.9 | -2.3% | 31.9 | 0.28 | 2026-08-11 |
Full series, every quarter: GET /empresas/ESPA3/trimestres
Dividends per year
| year | per share | payments |
|---|---|---|
| 2026 | R$ 0.0006 | 1 |
| 2025 | R$ 0.0393 | 3 |
| 2021 | R$ 0.1422 | 3 |
Piotroski F-Score 8/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2021 | BPA 1.01 | 851.4 | 867.8 |
| 2022 | DRE 3.02 | -576.5 | -588.5 |
| 2022 | DRE 3.03 | 330.0 | 318.0 |
| 2024 | DFC_MI 6.01 | 118.7 | 112.3 |
| 2021 | BPP 2.03.09 | 4.5 | 8.9 |
| 2023 | DFC_MI 6.01 | -96.2 | -92.3 |
| 2022 | DFC_MI 6.01 | 9.8 | 13.5 |
| 2021 | DRE 3.05 | 193.0 | 189.9 |
This company appears in
Other companies in Healthcare
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/ESPA3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 1,397 sessions, 2021-02-01 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 10:36 UTC. If this does not match /saude, you are reading a cached copy.